• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂溶性维生素(A、D和E)状态与COVID-19灭活疫苗体液免疫反应的关联

Association of fat-soluble vitamins (A, D, and E) status with humoral immune response to COVID-19 inactivated vaccination.

作者信息

Deng Yao, Huang Liting, Liu Peixin, Geng Xuyang, Lin Zefang, Zheng Zhixiong, Zhan Meixiao, Zhang Zhiren, Liu Junwei, Sun Taoping

机构信息

Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Precision Medical Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, China.

Department of Orthopedic, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, China.

出版信息

Front Nutr. 2023 May 16;10:1167920. doi: 10.3389/fnut.2023.1167920. eCollection 2023.

DOI:10.3389/fnut.2023.1167920
PMID:37260517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10227435/
Abstract

BACKGROUND

Fat-soluble vitamins (A, D, and E) are essential for the proper functioning of the immune system and are of central importance for infection risk in humans. Vitamins A, D, and E have been reported to be associated with the immune response following vaccination; however, their effects on the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination remain unknown.

METHODS

We measured the neutralizing antibody titers against wild type and omicron within 98 days after the third homologous boosting shot of inactivated SARS-CoV-2 vaccine (BBIBP-CorV or CoronaVac) in 141 healthy adults in a prospective, open-label study. High-performance liquid chromatography-tandem mass spectroscopy was used to determine the concentrations of plasma vitamins A, D, and E.

RESULTS

We found that the anti-wide-type virus and anti-omicron variant antibody levels significantly increased compared with baseline antibody levels (P < 0.001) after the third vaccination. 25(OH)D was significantly negatively associated with the baseline anti-wide-type virus antibody concentrations [beta (95% CI) = -0.331 (-0.659 ~ -0.003)] after adjusting for covariates. A potentially similar association was also observed on day 98 after the third vaccination [beta (95% CI) = -0.317 (-0.641 ~ 0.007)]. After adjusting for covariates, we also found that 25(OH)D was significantly negatively associated with the seropositivity of the anti-omicron variant antibody at day 98 after the third vaccination [OR (95% CI) = 0.940 (0.883 ~ 0.996)]. The association between plasma 25(OH)D with anti-wild-type virus antibody levels and seropositivity of anti-omicron variant antibodies were persistent in subgroup analyses. We observed no association between retinol/α-tocopherol and anti-wide-type virus antibody levels or anti-omicron variant antibody seropositive in our study.

CONCLUSION

The third inactivated SARS-CoV-2 vaccination significantly improved the ability of anti-SARS-CoV-2 infection in the human body. Higher vitamin D concentrations could significantly decrease the anti-wide-type virus-neutralizing antibody titers and anti-omicron variant antibody seropositive rate after the inactivated SARS-CoV-2 vaccination in people with adequate levels of vitamin D, better immune status, and stronger immune response; further studies comprising large cohorts of patients with different nutritional status are warranted to verify our results.

摘要

背景

脂溶性维生素(A、D和E)对于免疫系统的正常运作至关重要,对人类感染风险具有核心意义。据报道,维生素A、D和E与疫苗接种后的免疫反应有关;然而,它们对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种免疫反应的影响尚不清楚。

方法

在一项前瞻性、开放标签研究中,我们测量了141名健康成年人在接种灭活SARS-CoV-2疫苗(BBIBP-CorV或科兴疫苗)第三次同源加强注射后98天内针对野生型和奥密克戎的中和抗体滴度。采用高效液相色谱-串联质谱法测定血浆维生素A、D和E的浓度。

结果

我们发现,第三次接种疫苗后,抗野生型病毒和抗奥密克戎变异株抗体水平与基线抗体水平相比显著升高(P < 0.001)。调整协变量后,25(OH)D与基线抗野生型病毒抗体浓度显著负相关[β(95%CI)= -0.331(-0.659 ~ -0.003)]。在第三次接种疫苗后98天也观察到了类似的潜在关联[β(95%CI)= -0.317(-0.641 ~ 0.007)]。调整协变量后,我们还发现,第三次接种疫苗后98天,25(OH)D与抗奥密克戎变异株抗体的血清阳性率显著负相关[OR(95%CI)= 0.940(0.883 ~ 0.996)]。在亚组分析中,血浆25(OH)D与抗野生型病毒抗体水平以及抗奥密克戎变异株抗体血清阳性率之间的关联持续存在。在我们的研究中,未观察到视黄醇/α-生育酚与抗野生型病毒抗体水平或抗奥密克戎变异株抗体血清阳性之间的关联。

结论

第三次灭活SARS-CoV-2疫苗接种显著提高了人体抗SARS-CoV-2感染的能力。在维生素D水平充足、免疫状态较好且免疫反应较强的人群中,较高的维生素D浓度可能会显著降低灭活SARS-CoV-2疫苗接种后抗野生型病毒中和抗体滴度和抗奥密克戎变异株抗体血清阳性率;有必要开展包括不同营养状况的大量患者队列在内的进一步研究来验证我们的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/984a09b879d2/fnut-10-1167920-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/6ea5ed5eb44f/fnut-10-1167920-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/7152bc7fac85/fnut-10-1167920-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/da802f5cb531/fnut-10-1167920-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/984a09b879d2/fnut-10-1167920-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/6ea5ed5eb44f/fnut-10-1167920-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/7152bc7fac85/fnut-10-1167920-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/da802f5cb531/fnut-10-1167920-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b1a/10227435/984a09b879d2/fnut-10-1167920-g0004.jpg

相似文献

1
Association of fat-soluble vitamins (A, D, and E) status with humoral immune response to COVID-19 inactivated vaccination.脂溶性维生素(A、D和E)状态与COVID-19灭活疫苗体液免疫反应的关联
Front Nutr. 2023 May 16;10:1167920. doi: 10.3389/fnut.2023.1167920. eCollection 2023.
2
Immunogenicity Persistence of a Third-Dose Homologous BBIBP-CorV/CoronaVac Boosting Vaccination: A Prospective Open-Label Study.同源 BBIBP-CorV/科兴疫苗第三针加强免疫的免疫原性持久性:一项前瞻性开放标签研究。
Viral Immunol. 2024 Jan-Feb;37(1):16-23. doi: 10.1089/vim.2023.0075. Epub 2023 Dec 18.
3
Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.在中国,两剂科兴新冠疫苗后接种一剂mRNA和三种平台型新冠疫苗作为第三剂的免疫原性、持久性和安全性:一项随机、双盲、安慰剂对照的2期试验。
EClinicalMedicine. 2022 Sep 28;54:101680. doi: 10.1016/j.eclinm.2022.101680. eCollection 2022 Dec.
4
Association of selenium profile with neutralizing antibody response to inactivated SARS-CoV-2 vaccination.硒谱与对灭活的 SARS-CoV-2 疫苗接种的中和抗体反应之间的关联。
J Trace Elem Med Biol. 2023 Dec;80:127295. doi: 10.1016/j.jtemb.2023.127295. Epub 2023 Aug 25.
5
Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination.与两种新冠病毒灭活疫苗在初级系列接种后 12 个月诱导的中和抗体水平相关的因素。
Front Immunol. 2022 Sep 9;13:967051. doi: 10.3389/fimmu.2022.967051. eCollection 2022.
6
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.COVID-19 加强针接种后免疫反应的持久性及其与 COVID-19 奥密克戎感染的关联。
JAMA Netw Open. 2022 Sep 1;5(9):e2231778. doi: 10.1001/jamanetworkopen.2022.31778.
7
Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.两剂蛋白亚单位疫苗 MVC-COV1901 初免后加强接种多剂 mRNA 疫苗可增强针对新型 SARS-CoV-2 变异株的体液和细胞免疫应答。
Microbiol Spectr. 2022 Oct 26;10(5):e0060922. doi: 10.1128/spectrum.00609-22. Epub 2022 Aug 25.
8
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.感染或接种疫苗后针对 SARS-CoV-2 奥密克戎变异株的抗体亲合力和中和反应。
J Immunol Res. 2022 Aug 31;2022:4813199. doi: 10.1155/2022/4813199. eCollection 2022.
9
Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study.接种不同类型和剂量的新型冠状病毒2疫苗后疫苗接种后免疫球蛋白G抗体和T细胞免疫反应的评估:一项回顾性队列研究。
Front Med (Lausanne). 2023 Jan 10;9:1092646. doi: 10.3389/fmed.2022.1092646. eCollection 2022.
10
Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines.SARS-CoV-2 抗体反应动力学:既往感染 SARS-CoV-2 人群接种灭活疫苗后长达 9 个月的随访研究。
Viruses. 2023 Apr 4;15(4):917. doi: 10.3390/v15040917.

引用本文的文献

1
A scoping review: the impact of nutritional status on the efficacy, effectiveness, and immunogenicity of COVID-19 vaccines.一项范围综述:营养状况对新冠疫苗效力、效果和免疫原性的影响
Trop Dis Travel Med Vaccines. 2025 Jul 15;11(1):21. doi: 10.1186/s40794-025-00258-z.
2
Improving Vaccine Response through Probiotics and Micronutrient Supplementation: Evaluating the Role of TLR5 in Adult Female BALB/c Mice.通过益生菌和微量营养素补充改善疫苗反应:评估Toll样受体5在成年雌性BALB/c小鼠中的作用
Curr Pharm Des. 2025;31(3):233-242. doi: 10.2174/0113816128310203240823053538.
3
Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant-infected adults: A real-world cohort study.

本文引用的文献

1
Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings.充分了解 COVID-19 疫苗在多种真实环境中的疗效特征及其相关因素。
Front Immunol. 2022 Oct 25;13:947602. doi: 10.3389/fimmu.2022.947602. eCollection 2022.
2
Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population.孟加拉国人群对新冠疫苗免疫反应的比较
Vaccines (Basel). 2022 Sep 8;10(9):1498. doi: 10.3390/vaccines10091498.
3
Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial.
加强针接种和维生素 D 状态对奥密克戎变异株感染成年人抗体产生的交互作用:一项真实世界队列研究。
Clin Respir J. 2023 Oct;17(10):1067-1076. doi: 10.1111/crj.13694. Epub 2023 Sep 7.
维生素 D 补充剂对 SARS-CoV-2 疫苗的疗效或免疫原性没有影响:嵌套在 CORONAVIT 随机对照试验中的子研究。
Nutrients. 2022 Sep 16;14(18):3821. doi: 10.3390/nu14183821.
4
Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2.血清维生素D水平与SARS-CoV-2的BNT162b2疫苗免疫反应之间的关联
Biomedicines. 2022 Aug 17;10(8):1993. doi: 10.3390/biomedicines10081993.
5
Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece.与接种第二剂 BNT162b2 疫苗后 3 个月抗 SARS-CoV-2 抗体滴度相关的因素:希腊西部的一项纵向观察性队列研究。
BMJ Open. 2022 May 19;12(5):e057084. doi: 10.1136/bmjopen-2021-057084.
6
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine.年龄和维生素 D 影响 SARS-CoV-2 BNT162b2 疫苗首剂的抗体应答强度。
Curr Res Transl Med. 2022 Jul;70(3):103344. doi: 10.1016/j.retram.2022.103344. Epub 2022 Mar 16.
7
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study.同源 BBIBP-CorV 加强接种第三剂的安全性和免疫原性:一项前瞻性开放标签研究的中期结果。
Emerg Microbes Infect. 2022 Dec;11(1):639-647. doi: 10.1080/22221751.2022.2025746.
8
Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.接种灭活疫苗后 160 天内血清抗 SARS-CoV-2 抗体的反应和持续时间。
Front Immunol. 2021 Dec 23;12:786554. doi: 10.3389/fimmu.2021.786554. eCollection 2021.
9
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.奥密克戎变异株对疫苗加强后免疫血清的中和敏感性低于其他 SARS-CoV-2 变异株。
Emerg Microbes Infect. 2022 Dec;11(1):337-343. doi: 10.1080/22221751.2021.2022440.
10
Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination.BNT162b2 mRNA新冠疫苗接种后糖尿病和非糖尿病个体均产生强劲抗体水平。
Front Immunol. 2021 Nov 24;12:752233. doi: 10.3389/fimmu.2021.752233. eCollection 2021.